Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Mark

Showing results (241-250 of 331) with videos related to

Pageof 34
Sort By:
Circulation. Cardiovascular Imaging|February 5, 2019
Predictive Model for High-Risk Coronary Artery DiseaseJames J Jang, Manjushri Bhapkar, Adrian Coles, et al.
European Journal of Heart Failure|March 29, 2019
Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk scoreChristopher O'Connor, Mona Fiuzat, Hillary Mulder, et al.
American Heart Journal|December 26, 2021
The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trialMichael G Nanna, Sreekanth Vemulapalli, Christopher B Fordyce, et al.
JACC. Cardiovascular Interventions|February 6, 2009
Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) studyMariusz Kruk, Jacek Kadziela, Harmony R Reynolds, et al.
JAMA|June 4, 2014
Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%Sana M Al-Khatib, Anne S Hellkamp, Gregg C Fonarow, et al.
JACC. Heart Failure|January 7, 2019
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEFMelissa A Daubert, Kirkwood Adams, Eric Yow, et al.
JACC. Cardiovascular Imaging|March 28, 2016
Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE TrialKshipra Hemal, Neha J Pagidipati, Adrian Coles, et al.
JAMA Cardiology|January 12, 2018
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical TrialMaros Ferencik, Thomas Mayrhofer, Daniel O Bittner, et al.
American Heart Journal|August 14, 2018
Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trialRobert J Mentz, Christopher M O'Connor, Bradi B Granger, et al.
The New England Journal of Medicine|February 21, 2009
Quality of life after late invasive therapy for occluded arteriesDaniel B Mark, Wenqin Pan, Nancy E Clapp-Channing, et al.
Pageof 34

Showing results (241-250 of 331) with videos related to

Sort By:
Pageof 34
Circulation. Cardiovascular Imaging|February 5, 2019
Predictive Model for High-Risk Coronary Artery DiseaseJames J Jang, Manjushri Bhapkar, Adrian Coles, et al.
European Journal of Heart Failure|March 29, 2019
Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk scoreChristopher O'Connor, Mona Fiuzat, Hillary Mulder, et al.
American Heart Journal|December 26, 2021
The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trialMichael G Nanna, Sreekanth Vemulapalli, Christopher B Fordyce, et al.
JACC. Cardiovascular Interventions|February 6, 2009
Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) studyMariusz Kruk, Jacek Kadziela, Harmony R Reynolds, et al.
JAMA|June 4, 2014
Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%Sana M Al-Khatib, Anne S Hellkamp, Gregg C Fonarow, et al.
JACC. Heart Failure|January 7, 2019
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEFMelissa A Daubert, Kirkwood Adams, Eric Yow, et al.
JACC. Cardiovascular Imaging|March 28, 2016
Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE TrialKshipra Hemal, Neha J Pagidipati, Adrian Coles, et al.
JAMA Cardiology|January 12, 2018
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical TrialMaros Ferencik, Thomas Mayrhofer, Daniel O Bittner, et al.
American Heart Journal|August 14, 2018
Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trialRobert J Mentz, Christopher M O'Connor, Bradi B Granger, et al.
The New England Journal of Medicine|February 21, 2009
Quality of life after late invasive therapy for occluded arteriesDaniel B Mark, Wenqin Pan, Nancy E Clapp-Channing, et al.
Pageof 34